Stephens Inc’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-101
| Closed | -$1.07K | – | 1349 |
|
|
2023
Q4 | $1.07K | Hold |
101
| – | – | ﹤0.01% | 1248 |
|
|
2023
Q3 | $2K | Hold |
101
| – | – | ﹤0.01% | 1214 |
|
|
2023
Q2 | $7.73K | Hold |
101
| – | – | ﹤0.01% | 1221 |
|
|
2023
Q1 | $9.55K | Sell |
101
-67
| -40% | -$6.38K | ﹤0.01% | 1182 |
|
|
2022
Q4 | $16.3K | Hold |
168
| – | – | ﹤0.01% | 1152 |
|
|
2022
Q3 | $43K | Hold |
168
| – | – | ﹤0.01% | 1138 |
|
|
2022
Q2 | $31K | Hold |
168
| – | – | ﹤0.01% | 1195 |
|
|
2022
Q1 | $16K | Hold |
168
| – | – | ﹤0.01% | 1306 |
|
|
2021
Q4 | $27K | Hold |
168
| – | – | ﹤0.01% | 1314 |
|
|
2021
Q3 | $46K | Buy |
168
+34
| +25% | +$10.4K | ﹤0.01% | 1294 |
|
|
2021
Q2 | $53K | Hold |
134
| – | – | ﹤0.01% | 1280 |
|
|
2021
Q1 | $73K | Buy |
+134
| New | +$83.4K | ﹤0.01% | 1236 |
|
|
2020
Q4 | – | Sell |
-725
| Closed | -$274K | – | 1267 |
|
|
2020
Q3 | $274K | Buy |
725
+416
| +135% | +$184K | 0.01% | 921 |
|
|
2020
Q2 | $152K | Hold |
309
| – | – | ﹤0.01% | 1012 |
|
|
2020
Q1 | $114K | Buy |
309
+30
| +11% | +$15.5K | ﹤0.01% | 965 |
|
|
2019
Q4 | $198K | Buy |
279
+65
| +30% | +$44.7K | ﹤0.01% | 1009 |
|
|
2019
Q3 | $137K | Sell |
214
-9
| -4% | -$7.14K | ﹤0.01% | 1077 |
|
|
2019
Q2 | $195K | Hold |
223
| – | – | ﹤0.01% | 1073 |
|
|
2019
Q1 | $129K | Buy |
223
+14
| +7% | +$5.85K | ﹤0.01% | 1106 |
|
|
2018
Q4 | $59K | Hold |
209
| – | – | ﹤0.01% | 1074 |
|
|
2018
Q3 | $100K | Buy |
+209
| New | +$89.6K | ﹤0.01% | 1118 |
|
|
2017
Q3 | – | Sell |
-261
| Closed | -$243K | – | 860 |
|
|
2017
Q2 | $243K | Hold |
261
| – | – | 0.01% | 746 |
|
|
2017
Q1 | $248K | Hold |
261
| – | – | 0.01% | 725 |
|
|
2016
Q4 | $209K | Hold |
261
| – | – | 0.01% | 706 |
|
|
2016
Q3 | $220K | Hold |
261
| – | – | 0.01% | 685 |
|
|
2016
Q2 | $215K | Sell |
261
-30
| -10% | -$32.7K | 0.01% | 667 |
|
|
2016
Q1 | $324K | Buy |
291
+24
| +9% | +$24.6K | 0.02% | 533 |
|
|
2015
Q4 | $333K | Buy |
267
+6
| +2% | +$9.92K | 0.02% | 517 |
|
|
2015
Q3 | $352K | Sell |
261
-76
| -23% | -$125K | 0.02% | 514 |
|
|
2015
Q2 | $607K | Buy |
337
+104
| +45% | +$161K | 0.03% | 455 |
|
|
2015
Q1 | $377K | Sell |
233
-500
| -68% | -$741K | 0.02% | 559 |
|
|
2014
Q4 | $558K | Buy |
733
+533
| +267% | +$283K | 0.03% | 480 |
|
|
2014
Q3 | $79K | Buy |
+200
| New | +$96.4K | ﹤0.01% | 765 |
|
Other funds holding TCRT
MP
CB
ACM
Stephens Inc's TCRT Position: Q1 2024 in Review
Stephens Inc sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 101 shares — an estimated $1.07K sold.
Stephens Inc first reported a position in TCRT in Q3 2014 and held it in 33 quarters. The position peaked at $607K in Q2 2015. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.
- Stephens Inc reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
- Stephens Inc sold 101 Alaunos Therapeutics shares in Q1 2024, an estimated $1.07K.
- Stephens Inc first reported a position in Alaunos Therapeutics in Q3 2014 and held it in 33 quarters.
- Stephens Inc's Alaunos Therapeutics position peaked at $607K in Q2 2015.
- 45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.
Based on Stephens Inc's 13F filing for Q1 2024, filed 15 May 2024.